Weight Loss Medication Study for People with T2D

Now Enrolling Adults Ages 18 and Older

Now Enrolling

About this research study

Obesity is associated with an increased risk of developing hypertension, cardiovascular (CV) disease, obstructive sleep apnea, and many other medical conditions. Losing weight with lifestyle changes can be difficult to maintain long term, and weight-loss surgeries can present with major risks.

Velocity is conducting a clinical research study for overweight people with type 2 diabetes for an investigational medication for obesity.

Eligible participants...

  • Must be age 18 or older
  • Must have a BMI at least 27 kg/m2
  • Must have been diagnosed with type 2 diabetes for 180 days or more
  • Must have previously attempted to lose weight unsuccessfully
  • May receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Study Locations

Sioux City, Iowa • Velocity Clinical Research

4802 Sunnybrook Drive, Sioux City, IA 51106
Phone: (712) 639-6300

Valparaiso, Indiana • Velocity Clinical Research

55 University Drive, Suite 106, Valparaiso, IN 46383
Phone: (219) 464-8302
Row concave Shape Decorative svg added to top

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy